P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 427.3 Million USD | 20.74% |
| 2022 | 353.91 Million USD | 17.99% |
| 2021 | 299.93 Million USD | 105.5% |
| 2020 | 145.95 Million USD | 97.29% |
| 2019 | 73.98 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 527.93 Million USD | 12.21% |
| 2024 Q1 | 470.49 Million USD | 10.11% |
| 2023 Q2 | 514.05 Million USD | 29.69% |
| 2023 FY | 427.3 Million USD | 20.74% |
| 2023 Q4 | 427.3 Million USD | 7.94% |
| 2023 Q3 | 395.86 Million USD | -22.99% |
| 2023 Q1 | 396.38 Million USD | 12.0% |
| 2022 Q1 | 341.55 Million USD | 13.87% |
| 2022 Q4 | 353.91 Million USD | 6.93% |
| 2022 FY | 353.91 Million USD | 17.99% |
| 2022 Q3 | 330.97 Million USD | 0.75% |
| 2022 Q2 | 328.5 Million USD | -3.82% |
| 2021 FY | 299.93 Million USD | 105.5% |
| 2021 Q4 | 299.93 Million USD | 47.89% |
| 2021 Q3 | 202.81 Million USD | 15.52% |
| 2021 Q1 | 6.01 Million USD | -97.46% |
| 2021 Q2 | 175.56 Million USD | 2819.63% |
| 2020 Q4 | 236.65 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 145.95 Million USD | 97.29% |
| 2019 FY | 73.98 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 82.708% |
| Addus HomeCare Corporation | 317.73 Million USD | -34.486% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -229.812% |
| Amedisys, Inc. | 940.38 Million USD | 54.561% |
| American Oncology Network, Inc. | 368.72 Million USD | -15.887% |
| Astrana Health, Inc. | 522.59 Million USD | 18.234% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 75.785% |
| IMAC Holdings, Inc. | 1.89 Million USD | -22428.082% |
| biote Corp. | 191.84 Million USD | -122.739% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -491.409% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -107.506% |
| COMPASS Pathways plc | 50.24 Million USD | -750.477% |
| DocGo Inc. | 185.28 Million USD | -130.625% |
| The Ensign Group, Inc. | 2.68 Billion USD | 84.057% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -23.297% |
| InnovAge Holding Corp. | 247.85 Million USD | -72.403% |
| Assure Holdings Corp. | 22.84 Million USD | -1770.126% |
| The Joint Corp. | 62.37 Million USD | -585.014% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 46.871% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -11111.935% |
| ModivCare Inc. | 1.61 Billion USD | 73.477% |
| NewGenIvf Group Limited | 1.24 Million USD | -34320.248% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -3762.13% |
| Option Care Health, Inc. | 1.9 Billion USD | 77.589% |
| P3 Health Partners Inc. | 427.3 Million USD | 0.0% |
| The Pennant Group, Inc. | 394.17 Million USD | -8.405% |
| Surgery Partners, Inc. | 3.65 Billion USD | 88.316% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -46852.878% |
| Talkspace, Inc. | 23.57 Million USD | -1712.534% |
| Talkspace, Inc. | 23.57 Million USD | -1712.534% |
| The Oncology Institute, Inc. | 162.39 Million USD | -163.13% |
| The Oncology Institute, Inc. | 162.39 Million USD | -163.13% |